Birmingham, West Midlands -- (SBWIRE) -- 12/04/2013 -- Value Penny Stocks issues special report on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Alpha Natural Resources, Inc. (NYSE:ANR), Novavax, Inc. (NASDAQ:NVAX), Galena Biopharma Inc (NASDAQ:GALE).
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) opened its last trade at the price of $4.86. Its closing price was $4.83 after losing -2.03% for the day. The company traded with the total volume of 29.72 million shares, while its average trading volume remained 22.79 million shares. The beta of this stock stands at 0.81. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Has ARIA Found The Bottom and Ready To Move Up? Find Out Here
Alpha Natural Resources, Inc. (NYSE:ANR) percentage change surged 1.76% to close at $6.92 with the total traded volume of 15.05 million shares, along with average volume of 13.05 million shares. The 52 week range of the stock remained $4.78 - $10.74, while its day lowest price was $6.62. The share price hit the day highest price of $6.99. Alpha Natural Resources, Inc., together with its subsidiaries, engages in extracting, processing, and marketing steam and metallurgical coal in Virginia, West Virginia, Kentucky, Pennsylvania, and Wyoming.
For How Long ANR’s Gloss will Attract Investors? Find out via this report
Novavax, Inc. (NASDAQ:NVAX) traded on volume of 15.05 million shares in the last session against average volume of 3.19 million shares. The company started its trading session with the price of $3.87 and closed at $3.98 by scoring +3.38%. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Will NVAX Continue To Move Higher? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) started its last trading session with the price of $4.349 and closed at $4.33 by scoring -3.56%. The stock traded with total volume of 13.85 million shares, while the average trading volume remained 4.60 million shares. The beta value of this stock stands at 1.10. Day range for the stock was $4.15 - $4.77. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Will GALE Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)